US Patent 11187696 Pharmaceutical composition for treating or preventing obesity
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+405 characters)
Article
Patent abstract
Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111876960
Date of Patent
November 30, 2021
0Patent Application Number
159322340
Date Filed
August 18, 2016
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111876960
Date of Patent
November 30, 2021
0Patent Application Number
159322340
Date Filed
August 18, 2016
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11187696 Pharmaceutical composition for treating or preventing obesity
Infobox
Is a
Patent jurisdiction
Patent number
11187696
Date of patent
November 30, 2021
Patent application number
15932234
Date Filed
August 18, 2016
Patent primary examiner
Find more entities like US Patent 11187696 Pharmaceutical composition for treating or preventing obesity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.